Literature DB >> 25955461

Familial colorectal cancer.

M S Lung1, A H Trainer1,2,3, I Campbell1, L Lipton3.   

Abstract

Identifying individuals with a genetic predisposition to developing familial colorectal cancer (CRC) is crucial to the management of the affected individual and their family. In order to do so, the physician requires an understanding of the different gene mutations and clinical manifestations of familial CRC. This review summarises the genetics, clinical manifestations and management of the known familial CRC syndromes, specifically Lynch syndrome, familial adenomatous polyposis, MUTYH-associated neoplasia, juvenile polyposis syndrome and Peutz-Jeghers syndrome. An individual suspected of having a familial CRC with an underlying genetic predisposition should be referred to a familial cancer centre to enable pre-test counselling and appropriate follow up.
© 2015 Royal Australasian College of Physicians.

Entities:  

Keywords:  adenomatous polyposis coli; colorectal neoplasm; hereditary; hereditary nonpolyposis; neoplastic syndrome

Mesh:

Year:  2015        PMID: 25955461     DOI: 10.1111/imj.12736

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  5 in total

1.  Characteristics of colorectal cancers among Alaska Native people before and after implementing programs to promote screening.

Authors:  Sarah H Nash; Carla Britton; Diana Redwood
Journal:  J Cancer Policy       Date:  2021-07-12

2.  Do the risks of Lynch syndrome-related cancers depend on the parent of origin of the mutation?

Authors:  Shimelis Dejene Gemechu; Christine M van Vliet; Aung Ko Win; Jane C Figueiredo; Loic Le Marchand; Steven Gallinger; Polly A Newcomb; John L Hopper; Noralane M Lindor; Mark A Jenkins; James G Dowty
Journal:  Fam Cancer       Date:  2020-02-27       Impact factor: 2.446

3.  Universal molecular screening does not effectively detect Lynch syndrome in clinical practice.

Authors:  Beatrice Brennan; Christine T Hemmings; Ian Clark; Desmond Yip; Mitali Fadia; Douglas R Taupin
Journal:  Therap Adv Gastroenterol       Date:  2017-02-09       Impact factor: 4.409

4.  Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer.

Authors:  Zahra Montazeri; Xue Li; Christine Nyiraneza; Xiangyu Ma; Maria Timofeeva; Victoria Svinti; Xiangrui Meng; Yazhou He; Yacong Bo; Samuel Morgan; Sergi Castellví-Bel; Clara Ruiz-Ponte; Ceres Fernández-Rozadilla; Ángel Carracedo; Antoni Castells; Timothy Bishop; Daniel Buchanan; Mark A Jenkins; Temitope O Keku; Annika Lindblom; Fränzel J B van Duijnhoven; Anna Wu; Susan M Farrington; Malcolm G Dunlop; Harry Campbell; Evropi Theodoratou; Wei Zheng; Julian Little
Journal:  Gut       Date:  2019-12-09       Impact factor: 23.059

5.  Cancer-preventive Properties of an Anthocyanin-enriched Sweet Potato in the APCMIN Mouse Model.

Authors:  Khalid Asadi; Lynnette R Ferguson; Martin Philpott; Nishi Karunasinghe
Journal:  J Cancer Prev       Date:  2017-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.